Anyone doubting that Australia's use of health technology assessment masks a price negotiation should read the outcomes of the May Pharmaceutical Benefits Advisory Committee meeting.
A legally questionable outcome but one that reveals the truth of this process
June 23, 2024 Latest NewsBioPharmaCommentLatest Video
New Stories
-
Magentus partners with Amgen Australia to deliver AI-powered dermatology tool
September 27, 2024 - - Latest News -
The 'Week in Review' Podcast - 27 September
September 27, 2024 - - Podcast -
'Giving back is part of our DNA at Vertex, and something we are all very passionate about'
September 27, 2024 - - Latest News -
Gilead continues support for health equity through 2024 Community Grants Program
September 27, 2024 - - Latest News -
Members should demand more power and directors should embrace it
September 26, 2024 - - Latest News -
Organon medical director says 'it's time' to take a stand against online misinformation
September 26, 2024 - - Latest News -
Painaustralia appoints new chief executive to succeed Giulia Jones
September 26, 2024 - - Latest News